R. H, P. H, F. George, Jesnet Sebastian, Sana FATHIMA SALAM
{"title":"埃纳库拉姆地区新冠肺炎患者肺炎后综合征表现评估","authors":"R. H, P. H, F. George, Jesnet Sebastian, Sana FATHIMA SALAM","doi":"10.58537/jorangrau.2022.50.4.08","DOIUrl":null,"url":null,"abstract":"The study was conducted between 2021 and 2022 among the post-COVID patients in Ernakulam district of Kerala by assessing Dietary Diversity Score (DDS), comorbidities, symptoms during COVID and post-COVID, fatigue, stress, and insomnia. The research was a six-month community-based prospective cohort study comprising 250 patients.Out of the 250 patients, 41.6% were male and 58.4% were female. Among the patients, 26% had a high Dietary Diversity Score. The most common comorbidities observed were hypertension (24%), followed by obesity (20.8%), diabetes mellitus (19.2%), and cardiovascular disease (16.8%), respectively. During the period of infection, the most common symptom among patients was tiredness (89.2%), followed by fever (83.2%), headache (78.8%), dry cough (67.6%), and loss of taste or smell (56.4%). Breathlessness (30%), chest pain (26%), and diarrhea (9.2%) were the other significant symptoms. The most prevalent post-COVID symptoms in various systems among patients were loss of appetite (89%), weakness (62.4%), sore throat (51.6%), dry cough (40.4%), joint pain (26.8%), and pain/burning in the chest (14.8%). During COVID, 42.4% of the patients were severely fatigued, 61.2% of the patients had a moderate level of perceived stress, and 44.4% of the patients had subthreshold insomnia. During post-COVID, 80.4% were severely fatigued; moderate stress was found in 40%, of the subjects; and 22.8 % of the study subjects had subthreshold insomnia. The Pearson’s coefficient of correlation, ‘r’, between stress and insomnia among study subjects was 0.37. The obtained t-value for stress (7.14 > 2.58), fatigue (8.31> 2.58), and insomnia (10.97 > 2.58) were significant. Post-COVID is associated with comorbidities and disease severity. The prevalence of new-onset fatigue, perceived stress, and insomnia was significant among COVID-19 survivors.","PeriodicalId":220721,"journal":{"name":"THE JOURNAL OF RESEARCH ANGRAU","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ASSESSMENT OF POST-COVID SYNDROME MANIFESTATIONS AMONG COVID-19 PATIENTS IN ERNAKULAM DISTRICT\",\"authors\":\"R. H, P. H, F. George, Jesnet Sebastian, Sana FATHIMA SALAM\",\"doi\":\"10.58537/jorangrau.2022.50.4.08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The study was conducted between 2021 and 2022 among the post-COVID patients in Ernakulam district of Kerala by assessing Dietary Diversity Score (DDS), comorbidities, symptoms during COVID and post-COVID, fatigue, stress, and insomnia. The research was a six-month community-based prospective cohort study comprising 250 patients.Out of the 250 patients, 41.6% were male and 58.4% were female. Among the patients, 26% had a high Dietary Diversity Score. The most common comorbidities observed were hypertension (24%), followed by obesity (20.8%), diabetes mellitus (19.2%), and cardiovascular disease (16.8%), respectively. During the period of infection, the most common symptom among patients was tiredness (89.2%), followed by fever (83.2%), headache (78.8%), dry cough (67.6%), and loss of taste or smell (56.4%). Breathlessness (30%), chest pain (26%), and diarrhea (9.2%) were the other significant symptoms. The most prevalent post-COVID symptoms in various systems among patients were loss of appetite (89%), weakness (62.4%), sore throat (51.6%), dry cough (40.4%), joint pain (26.8%), and pain/burning in the chest (14.8%). During COVID, 42.4% of the patients were severely fatigued, 61.2% of the patients had a moderate level of perceived stress, and 44.4% of the patients had subthreshold insomnia. During post-COVID, 80.4% were severely fatigued; moderate stress was found in 40%, of the subjects; and 22.8 % of the study subjects had subthreshold insomnia. The Pearson’s coefficient of correlation, ‘r’, between stress and insomnia among study subjects was 0.37. The obtained t-value for stress (7.14 > 2.58), fatigue (8.31> 2.58), and insomnia (10.97 > 2.58) were significant. Post-COVID is associated with comorbidities and disease severity. The prevalence of new-onset fatigue, perceived stress, and insomnia was significant among COVID-19 survivors.\",\"PeriodicalId\":220721,\"journal\":{\"name\":\"THE JOURNAL OF RESEARCH ANGRAU\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"THE JOURNAL OF RESEARCH ANGRAU\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.58537/jorangrau.2022.50.4.08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"THE JOURNAL OF RESEARCH ANGRAU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58537/jorangrau.2022.50.4.08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ASSESSMENT OF POST-COVID SYNDROME MANIFESTATIONS AMONG COVID-19 PATIENTS IN ERNAKULAM DISTRICT
The study was conducted between 2021 and 2022 among the post-COVID patients in Ernakulam district of Kerala by assessing Dietary Diversity Score (DDS), comorbidities, symptoms during COVID and post-COVID, fatigue, stress, and insomnia. The research was a six-month community-based prospective cohort study comprising 250 patients.Out of the 250 patients, 41.6% were male and 58.4% were female. Among the patients, 26% had a high Dietary Diversity Score. The most common comorbidities observed were hypertension (24%), followed by obesity (20.8%), diabetes mellitus (19.2%), and cardiovascular disease (16.8%), respectively. During the period of infection, the most common symptom among patients was tiredness (89.2%), followed by fever (83.2%), headache (78.8%), dry cough (67.6%), and loss of taste or smell (56.4%). Breathlessness (30%), chest pain (26%), and diarrhea (9.2%) were the other significant symptoms. The most prevalent post-COVID symptoms in various systems among patients were loss of appetite (89%), weakness (62.4%), sore throat (51.6%), dry cough (40.4%), joint pain (26.8%), and pain/burning in the chest (14.8%). During COVID, 42.4% of the patients were severely fatigued, 61.2% of the patients had a moderate level of perceived stress, and 44.4% of the patients had subthreshold insomnia. During post-COVID, 80.4% were severely fatigued; moderate stress was found in 40%, of the subjects; and 22.8 % of the study subjects had subthreshold insomnia. The Pearson’s coefficient of correlation, ‘r’, between stress and insomnia among study subjects was 0.37. The obtained t-value for stress (7.14 > 2.58), fatigue (8.31> 2.58), and insomnia (10.97 > 2.58) were significant. Post-COVID is associated with comorbidities and disease severity. The prevalence of new-onset fatigue, perceived stress, and insomnia was significant among COVID-19 survivors.